References
- Martinez-Balibrea E, Abad A, Aranda E, Sastre J, Manzano JL, et al.: Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer. Eur J Cancer 44, 1229–1237, 2008. doi: 10.1016/j.ejca.2008.03.025
- Tol J, Koopman M, Cats A, Rodenburg CJ, Creemers GJ, et al.: Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 360, 563–572, 2009. doi: 10.1056/NEJMoa0808268
- Disel U, Gurkut O, Abali H, Kaleagasi H, Mertsoylu H, et al.: Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine. Cutan Ocul Toxicol 29, 140–142, 2010. doi: 10.3109/15569521003699585
- Woodcock J, Griffin JP, Behrman RE: Development of novel combination therapies. N Engl J Med 364, 985–987, 2011. doi: 10.1056/NEJMp1101548
- Abolmaali SS, Tamaddon AM, Dinarvand R: A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis. Cancer Chemother Pharmacol 71, 1115–1130, 2013. doi: 10.1007/s00280-012-2062-0
- Ashwanikumar N, Kumar NA, Nair SA, Kumar GS: Dual drug delivery of 5-fluorouracil (5-FU) and methotrexate (MTX) through random copolymeric nanomicelles of PLGA and polyethylenimine demonstrating enhanced cell uptake and cytotoxicity. Colloids Surf B Biointerfaces 122, 520–528, 2014. doi: 10.1016/j.colsurfb.2014.07.024
- Matsumura Y, Haruyama K, Hamaguchi T, Shirao K, Muro K, et al.: Effect of a 3-hour interval between methotrexate and 5-fluorouracil in the treatment of metastatic colorectal cancer. Jpn J Clin Oncol 32, 9–13, 2002.
- Bertino JR, Goker E, Gorlick R, Li WW, Banerjee D: Resistance Mechanisms to Methotrexate in Tumors. Oncologist 1, 223–226, 1996.
- Zhao R, Goldman ID: Resistance to antifolates. Oncogene 22, 7431–7457, 2003. doi: 10.1038/sj.onc.1206946
- Schmiegelow K: Advances in individual prediction of methotrexate toxicity: a review. Br J Haematol 146, 489–503, 2009. doi: 10.1111/j.1365-2141.2009.07765.x
- Griffith SM, Fisher J, Clarke S, Montgomery B, Jones PW, et al.: Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term? Rheumatology (Oxford) 39, 1102–1109, 2000.
- Selhub J: Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging 6, 39–42, 2002.
- Stover PJ, Field MS: Trafficking of intracellular folates. Adv Nutr 2, 325–331, 2011. doi: 10.3945/an.111.000596
- Hider SL, Bruce IN, Thomson W: The pharmacogenetics of methotrexate. Rheumatology (Oxford) 46, 1520–1524, 2007. doi: 10.1093/rheumatology/kem147
- Sharma P, Senthilkumar RD, Brahmachari V, Sundaramoorthy E, Mahajan A, et al.: Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis 5, 1, 2006. doi: 10.1186/1476-511X-5-1
- Cho E, Zeisel SH, Jacques P, Selhub J, Dougherty L, et al.: Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am J Clin Nutr 83, 905–911, 2006.
- Cavuoto P, Fenech MF: A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension. Cancer Treat Rev 38, 726–736, 2012. doi: 10.1016/j.ctrv.2012.01.004
- Lu S, Chen GL, Ren C, Kwabi-Addo B, Epner DE: Methionine restriction selectively targets thymidylate synthase in prostate cancer cells. Biochem Pharmacol 66, 791–800, 2003.
- Sugimura T, Birnbaum SM, Winitz M, Greenstein JP: Quantitative nutritional studies with water-soluble, chemically defined diets. IX. Further studies on d-glucosaminecontaining diets. Arch Biochem Biophys 83, 521–527, 1959.
- Jang YS, Jo YK, Sim JJ, Ji E, Jeong KY, et al.: Lactate calcium salt affects the viability of colorectal cancer cells via betaine homeostasis. Life Sci 147, 71–76, 2016. doi: 10.1016/j.lfs.2016.01.030
- Locasale JW: Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer 13, 572–583, 2013. doi: 10.1038/nrc3557
- Donaldson KO, Keresztesy JC: Naturally occurring forms of folic acid. II. Enzymatic conversion of methylenetetrahydrofolic acid to prefolic A-methyl-tetrahydrofolate. J Biol Chem 237, 1298–1304, 1962.
- Bhandari SD, Gregory JF, 3rd: Folic acid, 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate exhibit equivalent intestinal absorption, metabolism and in vivo kinetics in rats. J Nutr 122, 1847–1854, 1992.
- Hoffman RM: Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey. Expert Opin Biol Ther 15, 21–31, 2015. doi: 10.1517/14712598.2015.963050
- Park EI, Garrow TA: Interaction between dietary methionine and methyl donor intake on rat liver betaine-homocysteine methyltransferase gene expression and organization of the human gene. J Biol Chem 274, 7816–7824, 1999.
- Eklund M, Bauer E, Wamatu J, Mosenthin R: Potential nutritional and physiological functions of betaine in livestock. Nutr Res Rev 18, 31–48, 2005. doi: 10.1079/NRR200493
- Broer S, Gether U: The solute carrier 6 family of transporters. Br J Pharmacol 167, 256–278, 2012. doi: 10.1111/j.1476-5381.2012.01975.x
- Kempson SA, Zhou Y, Danbolt NC: The betaine/GABA transporter and betaine: roles in brain, kidney, and liver. Front Physiol 5, 159, 2014. doi: 10.3389/fphys.2014.00159
- Jeong KY, Mander P, Sim JJ, Kim HM: Combination of lactate calcium salt with 5-indanesulfonamide and alpha-cyano-4-hydroxycinnamic acid to enhance the antitumor effect on HCT116 cells via intracellular acidification. Oncol Lett 11, 1866–1872, 2016. doi: 10.3892/ol.2016.4137
- Jang YS, Sim JJ, Ji E, Jeong KY, Kim HM: Investigation of lactate calcium salt-induced beta-catenin destabilization in colorectal cancer cells. Life Sci 139, 160–165, 2015. doi: 10.1016/j.lfs.2015.08.012